Non-hormonal replacement therapy regimens: do they have an effect on cardiovascular risk?
CONCLUSION: Further research is needed to produce definite conclusions regarding the cardiovascular safety of non-hormonal medications for menopausal symptoms relief. PMID: 30205798 [PubMed - as supplied by publisher]
INTRODUCTION: Multiple rehabilitation therapies have been reported to be effective for poststroke balance impairment. However, the comparative effectiveness of these rehabilitation therapies is still unclear. Therefore, the aim of this study is to summaris...
Those who took testosterone replacement therapy had a 21% higher risk of cardiovascular events such as heart attack, stroke or mini-stroke than those who did not take the therapy. That increased risk translated into 128 more cardiovascular events.
Condition: Post-stroke Patients With Motor and Sensory Dysfunction Interventions: Drug: Ruyizhenbao Pill; Drug: Placebo of Ruyizhenbao Pill Sponsor: Guangzhou University of Traditional Chinese Medicine Recruiting
Condition: Evaluation of Cardiac Arrhythmias in Hand Surgery Using Local Anesthesia With Adrenaline Interventions: Procedure: Local anesthesia with lidocaine and adrenalin.; Drug: lidocaine and adrenalin; Drug: lidocaine and arterial blockage Sponsor: Uri farkash Recruiting
Condition: Stroke Intervention: Device: Occlutech PFO Occluder Sponsor: Occlutech International AB Not yet recruiting
Condition: Cerebrovascular Accident Intervention: Device: Evaluate the effects of the EO31 shoulder sling in adults post-stoke Sponsor: University Hospital, Toulouse Recruiting
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 23, 2019 issue
Publication date: August 2019Source: Anaesthesia Critical Care &Pain Medicine, Volume 38, Issue 4Author(s): Thomas Geeraerts, Ségolène Mrozek, Clément Monet, Jean-Marc Olivot
A global initiative aims to get neurology experts working together to reduce the incidence of stroke in order to reduce dementia.Medscape Medical News
When insurance companies refuse to cover cholesterol-lowering drugs, it puts patients at risk for stroke and heart ailments, a new study says.